These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34796563)
1. Efficacy of olanexidine gluconate in canine superficial pyoderma: a randomised, single-blinded controlled trial. Hsiao YH; Imanishi I; Iyori K Vet Dermatol; 2021 Dec; 32(6):664-e174. PubMed ID: 34796563 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. Clark SM; Loeffler A; Bond R J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a combined (4% chlorhexidine digluconate shampoo and solution) protocol in MRS and non-MRS canine superficial pyoderma: a randomized, blinded, antibiotic-controlled study. Borio S; Colombo S; La Rosa G; De Lucia M; Damborg P; Guardabassi L Vet Dermatol; 2015 Oct; 26(5):339-44, e72. PubMed ID: 26140535 [TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma. Larsuprom L; Rungroj N; Lekcharoensuk C; Pruksakorn C; Kongkiatpaiboon S; Chen C; Sukatta U Vet Dermatol; 2019 Dec; 30(6):487-e145. PubMed ID: 31441182 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial studies of volatile oil from Atractylodis Rhizoma against Staphylococcus pseudintermedius and multidrug resistant Staphylococcus pseudintermedius strains from canine pyoderma. Xie T; Lin J; Lin D; Zhang D; Xu X; Zhu N; Lin J J Ethnopharmacol; 2024 Jan; 319(Pt 3):117326. PubMed ID: 37879504 [TBL] [Abstract][Full Text] [Related]
6. In vitro antiseptic susceptibilities for Staphylococcus pseudintermedius isolated from canine superficial pyoderma in Japan. Murayama N; Nagata M; Terada Y; Okuaki M; Takemura N; Nakaminami H; Noguchi N Vet Dermatol; 2013 Feb; 24(1):126-9.e29. PubMed ID: 23331688 [TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of a honey-based gel against canine clinical isolates of Staphylococcus pseudintermedius and Malassezia pachydermatis. Oliveira AMP; Devesa JSP; Hill PB Vet Dermatol; 2018 Jun; 29(3):180-e65. PubMed ID: 29569291 [TBL] [Abstract][Full Text] [Related]
8. Low prevalence of mupirocin resistance in Staphylococcus pseudintermedius isolates from canine pyoderma in Korea. Park JH; Kang JH; Hyun JE; Hwang CY Vet Dermatol; 2018 Apr; 29(2):95-e37. PubMed ID: 29363211 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs. Valentine BK; Dew W; Yu A; Weese JS Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904 [TBL] [Abstract][Full Text] [Related]
10. Efficacy study of a topical treatment with a plant extract with antibiofilm activities using an in vivo model of canine superficial pyoderma. Bäumer W; Jacobs M; Tamamoto-Mochizuki C Vet Dermatol; 2020 Apr; 31(2):86-89. PubMed ID: 31737969 [TBL] [Abstract][Full Text] [Related]
11. Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma. Hensel N; Zabel S; Hensel P Vet Dermatol; 2016 Apr; 27(2):72-8e20. PubMed ID: 26909526 [TBL] [Abstract][Full Text] [Related]
12. Canine superficial bacterial pyoderma: evaluation of skin surface sampling methods and antimicrobial susceptibility of causal Staphylococcus isolates. Ravens PA; Vogelnest LJ; Ewen E; Bosward KI; Norris JM Aust Vet J; 2014 May; 92(5):149-55. PubMed ID: 24766044 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antimicrobial-resistant staphylococci in nares and affected sites of pet dogs with superficial pyoderma. Nakaminami H; Okamura Y; Tanaka S; Wajima T; Murayama N; Noguchi N J Vet Med Sci; 2021 Feb; 83(2):214-219. PubMed ID: 33342967 [TBL] [Abstract][Full Text] [Related]
14. Staphylococci isolated from cats in Italy with superficial pyoderma and allergic dermatitis: Characterisation of isolates and their resistance to antimicrobials. Cavana P; Robino P; Stella MC; Bellato A; Crosaz O; Fiora SR; Nebbia P Vet Dermatol; 2023 Feb; 34(1):14-21. PubMed ID: 36221849 [TBL] [Abstract][Full Text] [Related]
15. Lincosamide resistance is less frequent in Denmark in Staphylococcus pseudintermedius from first-time canine superficial pyoderma compared with skin isolates from clinical samples with unknown clinical background. Larsen R; Boysen L; Berg J; Guardabassi L; Damborg P Vet Dermatol; 2015 Jun; 26(3):202-5, e43-4. PubMed ID: 25891140 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Murayama N; Nagata M; Terada Y; Shibata S; Fukata T Vet Dermatol; 2010 Dec; 21(6):586-92. PubMed ID: 20529012 [TBL] [Abstract][Full Text] [Related]
17. Residual antibacterial activity of canine hair treated with five mousse products against Staphylococcus pseudintermedius in vitro. Ramos SJ; Woodward M; Hoppers SM; Liu CC; Pucheu-Haston CM; Mitchell MS Vet Dermatol; 2019 Jun; 30(3):183-e57. PubMed ID: 30887651 [TBL] [Abstract][Full Text] [Related]
18. Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report. Vincze S; Paasch A; Walther B; Ruscher C; Lübke-Becker A; Wieler LH; Barbara K Berl Munch Tierarztl Wochenschr; 2010; 123(9-10):353-8. PubMed ID: 21038805 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with methicillin-resistant versus methicillin-susceptible Staphylococcus pseudintermedius infection in dogs. Weese JS; Faires MC; Frank LA; Reynolds LM; Battisti A J Am Vet Med Assoc; 2012 Jun; 240(12):1450-5. PubMed ID: 22657928 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of in Vitro Bactericidal Activity of 1.5% Olanexidine Gluconate, a Novel Biguanide Antiseptic Agent. Seyama S; Nishioka H; Nakaminami H; Nakase K; Wajima T; Hagi A; Noguchi N Biol Pharm Bull; 2019 Mar; 42(3):512-515. PubMed ID: 30568106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]